Streetbeat News

Analyst Ratings

DXCM

The article provides a detailed comparison of DexCom (NASDAQ:DXCM) with its competitors in the Health Care Equipment & Supplies industry. DexCom's P/E, P/B, and P/S ratios are higher than the industry average, indicating a premium valuation. The company's ROE is slightly above the industry average, and its revenue growth significantly outperforms the industry average. However, DexCom's EBITDA and gross profit are below the industry average, suggesting potential challenges in profitability or financial health.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 4:01 pm

CTAS

The article provides a comprehensive analysis of Cintas (NASDAQ:CTAS) in comparison to its major competitors within the Commercial Services & Supplies industry. The analysis reveals that Cintas has higher PE, PB, and PS ratios compared to its peers, suggesting potential overvaluation. However, the company's high EBITDA, gross profit, and lower debt-to-equity ratio indicate strong operational performance and financial health.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 4:00 pm

CSX

The article provides a detailed comparison of CSX Corporation (NASDAQ:CSX) with its competitors in the Road & Rail industry. CSX's low Price to Earnings (PE), Price to Book (PB), and Price to Sales (PS) ratios suggest undervaluation, indicating potential for future price appreciation. However, the company's low Return on Equity (ROE), Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), and gross profit, along with high revenue growth, suggest potential challenges in generating profits and efficiently managing operations.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 4:00 pm

ARDX

HC Wainwright & Co. analyst Ed Arce maintains a 'Buy' rating on Ardelyx (NASDAQ:ARDX) and raises the price target from $9 to $11.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:58 pm

AME

RBC Capital analyst Deane Dray has maintained an 'Outperform' rating on AMETEK (AME) and raised the price target from $183 to $186.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:57 pm

TSX:TIH

RBC Capital analyst Sabahat Khan maintains an Outperform rating on Toromont Industries (TSX:TIH) but lowers the price target from C$131 to C$125.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:52 pm

URG

Roth MKM analyst Joe Reagor maintains a Buy rating on Ur-Energy (AMEX:URG) but lowers the price target from $2.4 to $2.2.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:50 pm

BIOX

Roth MKM analyst Brian Wright maintains a Buy rating on Bioceres Crop Solutions (NASDAQ:BIOX) but lowers the price target from $31 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:47 pm

FNV

RBC Capital analyst Josh Wolfson has maintained a 'Sector Perform' rating on Franco-Nevada (NYSE:FNV) and lowered the price target from $155 to $140.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:44 pm

STEM

Roth MKM analyst Justin Clare has maintained a Neutral rating on Stem (NYSE:STEM) and lowered the price target from $6 to $3.7.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 3:43 pm